Johnson & Johnson Raises 2024 Operational Sales View To $89.2B-$89.6B Vs. Prior Guidance Of $88.7B-$89.1B, Reaffirms 2024 Reported Sales Guidance Of $88B-$88.4B Versus Consensus of $88.74B
Portfolio Pulse from Benzinga Newsdesk
Johnson & Johnson has raised its 2024 operational sales forecast to $89.2 billion-$89.6 billion, up from the previous guidance of $88.7 billion-$89.1 billion. The company also reaffirmed its 2024 reported sales guidance of $88 billion-$88.4 billion, which is in line with the consensus estimate of $88.74 billion.
July 17, 2024 | 10:28 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Johnson & Johnson has increased its 2024 operational sales forecast, indicating stronger expected performance. The reaffirmation of reported sales guidance aligns with market expectations.
The increase in operational sales forecast suggests improved business performance, which is likely to positively impact investor sentiment. The reaffirmation of reported sales guidance in line with consensus reduces uncertainty.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100